Why the study?
Does pravastatin 40 mg/d reduce major cardiovascular disease events in older patients (65-75 years) with previous myocardial infarction or unstable angina?
Does pravastatin 40 mg/d reduce major cardiovascular disease events in older patients (65-75 years) with previous myocardial infarction or unstable angina?
Pravastatin provides significant relative and greater absolute cardiovascular benefits in older patients compared to younger patients with coronary heart disease.
No takes yet. Share an insight, caveat, or question.
Supports pravastatin for secondary prevention in older adults; extends RCT evidence to ages 65-75.
Hunt et al. (2001) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: